Answers are grounded in this paper and cite their sources.
Background/Objectives: Histone deacetylase 7 (HDAC7), a class IIa epigenetic regulator, is implicated in the progression of multiple malignancies; however, the development of selective HDAC7 inhibitors remains challenging due to the high structural conservation among HDAC isoforms, particularly with the closely related class IIb enzyme HDAC6. Methods: In this study, we screened a focused library of hydroxamate-based inhibitors to define the structural determinants governing HDAC7 isoform selectivity. While most compounds exhibited a strong preference for HDAC6, inhibitors bearing aromatic linkers—especially biphenyl motifs—displayed enhanced affinity toward HDAC7. Results: Among these, compound 18 emerged as a lead candidate, exhibiting a 9.3-fold selectivity for HDAC7 over HDAC6. Integrated molecular docking and site-directed mutagenesis analyses revealed that the biphenyl motif of 18 engages key hydrophobic gating residues (F679 and F738) and occupies a class IIa-specific auxiliary hydrophobic pocket adjacent to the catalytic center. This pocket, created by the characteristic Tyr-to-His substitution in HDAC7, is sterically inaccessible in HDAC6 and underlies the observed isoform discrimination. In contrast, the incorporation of bulky cap groups, such as quinazoline-2,4-dione, diminished selectivity and shifted inhibition toward a pan-HDAC profile. Conclusions: Collectively, our findings establish a linker-driven mechanism for HDAC7 recognition and demonstrate that the exploitation of a previously underappreciated class IIa-specific hydrophobic pocket represents an effective strategy for the rational design of HDAC7-targeted inhibitors.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: